Jl. Freudenheim et al., Alcohol dehydrogenase 3 genotype modification of the association of alcohol consumption with breast cancer risk, CANC CAUSE, 10(5), 1999, pp. 369-377
Objectives: Because alcohol dehydrogenase 3 (ADH(3)) is rate-limiting in al
cohol oxidation and is polymorphic, we examined ADH(3) genotype in relation
to alcohol intake and breast cancer risk.
Methods: We conducted a case-control study among Caucasian women aged 40-85
with incident, pathologically confirmed breast cancer and controls, freque
ncy-matched on age and county. Queries included alcohol intake in the past
20 years. Genomic DNA was genotyped for the exon VIII ADH polymorphism by P
CR followed by restriction enzyme digestion. Computation of odds ratios (OR
) and 95% confidence intervals (CI) was by unconditional logistic regressio
n.
Results: We found increased risk among pre- (OR 2.3, 95%, CI 1.2-4.3) but n
ot postmenopausal women (OR 1.1, 95% CI 0.7-1.7) associated with ADH(3)(1-1
) compared to ADH(3)(1-2) and ADH(3)(2-2) genotypes. Risk was increased for
premenopausal women with the ADH(3)(1-1) genotype and alcohol intake above
the median (OR 3.6, 95% CI 1.5-8.8) compared to lighter drinkers with the
ADH(3)(2-2) or ADH(3)(1-2) genotypes. ORs were close to null for premenopau
sal women in other drinking and genotype groups and for postmenopausal wome
n categorized by genotype and alcohol consumption.
Conclusion: Among premenopausal women there may be a group more genetically
susceptible to an alcohol consumption effect on breast cancer risk.